Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Cited In for PubMed (Select 15827147)

1.

Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.

Kiss G, Holl JM, Williams GM, Alonas E, Vanover D, Lifland AW, Gudheti M, Guerrero-Ferreira RC, Nair V, Yi H, Graham BS, Santangelo PJ, Wright ER.

J Virol. 2014 Jul;88(13):7602-17. doi: 10.1128/JVI.00256-14. Epub 2014 Apr 23.

2.

Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Van den Broeke C, Jacob T, Favoreel HW.

Small GTPases. 2014;5:e28318. doi: 10.4161/sgtp.28318. Epub 2014 Mar 24. Review.

3.

The Thr205 phosphorylation site within respiratory syncytial virus matrix (M) protein modulates M oligomerization and virus production.

Bajorek M, Caly L, Tran KC, Maertens GN, Tripp RA, Bacharach E, Teng MN, Ghildyal R, Jans DA.

J Virol. 2014 Jun;88(11):6380-93. doi: 10.1128/JVI.03856-13. Epub 2014 Mar 26.

4.

Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells.

Alonas E, Lifland AW, Gudheti M, Vanover D, Jung J, Zurla C, Kirschman J, Fiore VF, Douglas A, Barker TH, Yi H, Wright ER, Crowe JE Jr, Santangelo PJ.

ACS Nano. 2014 Jan 28;8(1):302-15. doi: 10.1021/nn405998v. Epub 2013 Dec 23.

5.

Atomic force microscopic investigation of respiratory syncytial virus infection in HEp-2 cells.

Tiwari PM, Eroglu E, Boyoglu-Barnum S, He Q, Willing GA, Vig K, Dennis VA, Singh SR.

J Microsc. 2014 Jan;253(1):31-41. doi: 10.1111/jmi.12095. Epub 2013 Nov 19.

6.

The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism.

Baviskar PS, Hotard AL, Moore ML, Oomens AG.

J Virol. 2013 Oct;87(19):10730-41. doi: 10.1128/JVI.03086-12. Epub 2013 Jul 31.

7.

Gold nanorod vaccine for respiratory syncytial virus.

Stone JW, Thornburg NJ, Blum DL, Kuhn SJ, Wright DW, Crowe JE Jr.

Nanotechnology. 2013 Jul 26;24(29):295102. doi: 10.1088/0957-4484/24/29/295102. Epub 2013 Jun 25.

8.

Molecular mechanisms driving respiratory syncytial virus assembly.

Shaikh FY, Crowe JE Jr.

Future Microbiol. 2013 Jan;8(1):123-31. doi: 10.2217/fmb.12.132. Review.

9.

Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins.

Shaikh FY, Utley TJ, Craven RE, Rogers MC, Lapierre LA, Goldenring JR, Crowe JE Jr.

PLoS One. 2012;7(7):e40826. doi: 10.1371/journal.pone.0040826. Epub 2012 Jul 13.

10.

Poxvirus cell entry: how many proteins does it take?

Moss B.

Viruses. 2012 May;4(5):688-707. doi: 10.3390/v4050688. Epub 2012 Apr 27. Review.

11.

A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.

Shaikh FY, Cox RG, Lifland AW, Hotard AL, Williams JV, Moore ML, Santangelo PJ, Crowe JE Jr.

MBio. 2012 Feb 7;3(1). pii: e00270-11. doi: 10.1128/mBio.00270-11. Print 2012.

12.

The human respiratory syncytial virus matrix protein is required for maturation of viral filaments.

Mitra R, Baviskar P, Duncan-Decocq RR, Patel D, Oomens AG.

J Virol. 2012 Apr;86(8):4432-43. doi: 10.1128/JVI.06744-11. Epub 2012 Feb 8.

13.

The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components.

Laliberte JP, Weisberg AS, Moss B.

PLoS Pathog. 2011 Dec;7(12):e1002446. doi: 10.1371/journal.ppat.1002446. Epub 2011 Dec 15.

14.

Small rho GTPases and cholesterol biosynthetic pathway intermediates in African swine fever virus infection.

Quetglas JI, Hernáez B, Galindo I, Muñoz-Moreno R, Cuesta-Geijo MA, Alonso C.

J Virol. 2012 Feb;86(3):1758-67. doi: 10.1128/JVI.05666-11. Epub 2011 Nov 23.

15.

Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles.

Chang TH, Segovia J, Sabbah A, Mgbemena V, Bose S.

Virology. 2012 Jan 20;422(2):205-13. doi: 10.1016/j.virol.2011.10.029. Epub 2011 Nov 14.

16.

The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell-cell fusion.

Wurth MA, Schowalter RM, Smith EC, Moncman CL, Dutch RE, McCann RO.

Virology. 2010 Aug 15;404(1):117-26. doi: 10.1016/j.virol.2010.04.024.

17.

Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly.

Radhakrishnan A, Yeo D, Brown G, Myaing MZ, Iyer LR, Fleck R, Tan BH, Aitken J, Sanmun D, Tang K, Yarwood A, Brink J, Sugrue RJ.

Mol Cell Proteomics. 2010 Sep;9(9):1829-48. doi: 10.1074/mcp.M110.001651. Epub 2010 Jun 8.

18.

Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion.

Huang K, Incognito L, Cheng X, Ulbrandt ND, Wu H.

J Virol. 2010 Aug;84(16):8132-40. doi: 10.1128/JVI.02699-09. Epub 2010 Jun 2.

19.

Reciprocal regulation of AKT and MAP kinase dictates virus-host cell fusion.

Sharma NR, Mani P, Nandwani N, Mishra R, Rana A, Sarkar DP.

J Virol. 2010 May;84(9):4366-82. doi: 10.1128/JVI.01940-09. Epub 2010 Feb 17.

20.

The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism.

Ghildyal R, Ho A, Dias M, Soegiyono L, Bardin PG, Tran KC, Teng MN, Jans DA.

J Virol. 2009 Jun;83(11):5353-62. doi: 10.1128/JVI.02374-08. Epub 2009 Mar 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk